VYGR – voyager therapeutics, inc. (US:NASDAQ)

News

Voyager Therapeutics (VYGR) was upgraded by Truist Financial Corporation to "strong-buy".
Voyager Therapeutics, Inc. (VYGR) Presents at Stifel 2026 Virtual CNS Forum Transcript [Seeking Alpha]
Voyager Therapeutics Conference: CEO Calls 2026 “Year of Tau,” Eyes BBB Capsid Clinic Debut [Yahoo! Finance]
Voyager Therapeutics (VYGR) had its "buy" rating reaffirmed by HC Wainwright. They now have a $25.00 price target on the stock.
Voyager Therapeutics (VYGR) was upgraded by Wall Street Zen from "sel
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com